The role of hepatokines in NAFLD.
The role of hepatokines in NAFLD.
复制标题
DOI:
10.1016/j.cmet.2023.01.006
复制
发表时间:
2023-02-07
期刊:
影响因子:
29
通讯作者:
White, Morris F.
中科院分区:
文献类型:
--
作者:
Stefan, Norbert;Schick, Fritz;Birkenfeld, Andreas L.;Haering, Hans-Ulrich;White, Morris F.
Non-alcoholic fatty liver disease (NAFLD) is not only a consequence of insulin resistance, but it is also an important cause of insulin resistance and major non-communicable diseases (NCDs). The close relationship of NAFLD with visceral obesity obscures the role of fatty liver from visceral adiposity as the main pathomechanism of insulin resistance and NCDs. To overcome this limitation, in analogy to the concept of adipokines, in 2008 we introduced the term hepatokines to describe the role of fetuin-A in metabolism. Since then, several other hepatokines were tested for their effects on metabolism. Here we address the dysregulation of hepatokines in people with NAFLD. Then, we discuss pathophysiological mechanisms of cardiometabolic diseases specifically related to NAFLD by focusing on hepatokine-related organ crosstalk. Finally, we propose how the determination of major hepatokines and adipokines can be used for pathomechanism-based clustering of insulin resistance in NAFLD and visceral obesity to better implement precision medicine in clinical practice.
登录
查看更多内容
影响因子:
6
作者:
Cornejo, Pierre-Jean;Vergoni, Bastien;Ohanna, Mickael;Angot, Brice;Gonzalez, Teresa;Jager, Jennifer;Tanti, Jean-Francois;Cormont, Mireille
通讯作者:
Cormont, Mireille
影响因子:
10.9
作者:
Brown, Melissa L.;Schneyer, Alan L.
通讯作者:
Schneyer, Alan L.
影响因子:
4.8
作者:
Davey, Jonathan R.;Estevez, Emma;Gregorevic, Paul
通讯作者:
Gregorevic, Paul
影响因子:
82.9
作者:
Friedman SL;Neuschwander-Tetri BA;Rinella M;Sanyal AJ
通讯作者:
Sanyal AJ
影响因子:
15.9
作者:
Donnelly, KL;Smith, CI;Parks, EJ
通讯作者:
Parks, EJ